腹股沟结内CT淋巴管造影用于胸导管损伤:快速扫描的可行性
回顾性评估疑似胸导管损伤患者行腹股沟淋巴结穿刺CT淋巴管造影(CTL)与动态增强MR淋巴管造影(DCMRL)的表现,CTL技术成功率96.5%、中位扫描时间17分钟、平均有效剂量7.7 mSv,能显示中央淋巴管及胸导管损伤类型。
要点
- CTL中位扫描时间17分钟、中位增强扫描4次,DCMRL分别为36分钟和8次。
- CTL技术成功率96.5%(55/57),DCMRL为93.2%(41/44)。
- CTL平均有效剂量7.7 mSv,成人9.0 mSv、儿童3.3 mSv。
核心结论
- CTL能以较短检查时间和可接受的辐射剂量成功显示中央淋巴管及胸导管损伤。
研究设计与样本
- 回顾性评估2017年8月至2024年7月单家三级转诊中心疑似胸导管损伤患者,行CTL 57例(平均年龄48.3±26.4岁,儿童13例)和DCMRL 44例(平均年龄60.2±16.3岁,儿童2例),均经腹股沟淋巴结穿刺。
关键影像表现/征象
- CTL显示胸导管损伤类型为部分断裂42例(76.4%)、完全断裂10例(18.2%)、封堵状态3例(5.5%)。
- CTL中位总操作时间17分钟(中位增强扫描4次),DCMRL为36分钟(中位增强扫描8次)。
- CTL技术成功55/57(96.5%),DCMRL技术成功41/44(93.2%)。
诊断标准与关键数值
- CTL平均有效剂量7.7 mSv,成人9.0 mSv、儿童3.3 mSv。
- 乳糜漏改善率CTL为100.0%,DCMRL为95.5%。
临床应用与阅片要点
- 作者指出,当需要快速成像或更好的可及性时,CTL可能是淋巴管造影的有价值选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To demonstrate the optimized protocol for CT lymphangiography (CTL) and describe its performance in pediatric and adult patients with suspected thoracic duct injury.
MATERIALS AND METHODS: Patients with suspected thoracic duct injury who underwent either CTL or dynamic contrast-enhanced MR lymphangiography (DCMRL) between August 2017 and July 2024 at a tertiary referral center were retrospectively evaluated. CTL and DCMRL were performed using inguinal lymph node cannulation. Total scan time, the number of enhanced scans, technical success, results of lymphatic interventions, and clinical outcomes were recorded. Radiation dose was recorded for CTL. The acquisition results of CTL were described with reference to the results from a previously performed cohort of DCMRL.
RESULTS: A total of 57 CTL (mean age, 48.3 ± 26.4 years; 13 pediatric patients) and 44 DCMRL (mean age, 60.2 ± 16.3 years; 2 pediatric patients) procedures were included. Technical success was achieved in 96.5% (55/57) of CTL and 93.2% (41/44) of DCMRL procedures. Median of total procedure time was 17 min for CTL (median of 4 enhanced scans) while 36 min for DCMRL (median of 8 enhanced scans). The CTL findings for thoracic duct injury types were 42 partial disruptions (76.4%), 10 total disruptions (18.2%), and 3 sealed-off status (5.5%). The mean effective dose of CTL was 7.7 mSv (9.0 mSv for adults, 3.3 mSv for pediatric patients). Improvement in chylous leakage was observed in 100.0% of CTL and 95.5% of DCMRL patients.
CONCLUSION: CTL successfully depicted central lymphatics and thoracic duct injury with short examination times and an acceptable radiation dose.
KEY POINTS: Question The utility of contrast-enhanced CT lymphangiography (CTL) has only been explored in animal studies and small case series. Findings Performed in patients with thoracic duct injury, CTL successfully depicted central lymphatics (median scan time, 17 min; mean effective dose, 7.7 mSv). Clinical relevance CTL can be a valuable option for lymphangiography, particularly when rapid imaging or better accessibility is needed.
引用
- Ahn Y, Koo HJ, Choe J, et al. Inguinal intranodal CT lymphangiography for thoracic duct injury: feasibility with rapid scanning. Eur Radiol. 2025. PMID: 40883522. doi:10.1007/s00330-025-11939-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。